Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.

Miyata M, Hirabayashi Y, Munakata Y, Urata Y, Saito K, Okuno H, Yoshida M, Kodera T, Watanabe R, Miyamoto S, Ishii T, Nakazawa S, Takemori H, Ando T, Kanno T, Komagamine M, Kato I, Takahashi Y, Komatsuda A, Endo K, Murai C, Takakubo Y, Miura T, Sato Y, Ichikawa K, Konta T, Chiba N, Muryoi T, Kobayashi H, Fujii H, Sekiguchi Y, Hatakeyama A, Ogura K, Sakuraba H, Asano T, Kanazawa H, Suzuki E, Takasaki S, Asakura K, Suzuki Y, Takagi M, Nakayama T, Watanabe H, Miura K, Mori Y, Michinoku Tocilizumab Study Group

Open source

DOI
10.5387/fms.2022-06
Published
2023 Apr 5
Container
Fukushima journal of medical science
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5387/fms.2022-06,
  title = {Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.},
  author = {Miyata M and Hirabayashi Y and Munakata Y and Urata Y and Saito K and Okuno H and Yoshida M and Kodera T and Watanabe R and Miyamoto S and Ishii T and Nakazawa S and Takemori H and Ando T and Kanno T and Komagamine M and Kato I and Takahashi Y and Komatsuda A and Endo K and Murai C and Takakubo Y and Miura T and Sato Y and Ichikawa K and Konta T and Chiba N and Muryoi T and Kobayashi H and Fujii H and Sekiguchi Y and Hatakeyama A and Ogura K and Sakuraba H and Asano T and Kanazawa H and Suzuki E and Takasaki S and Asakura K and Suzuki Y and Takagi M and Nakayama T and Watanabe H and Miura K and Mori Y and Michinoku Tocilizumab Study Group},
  year = {2023},
  journal = {Fukushima journal of medical science},
  doi = {10.5387/fms.2022-06},
  url = {https://doi.org/10.5387/fms.2022-06}
}

RIS

TY  - JOUR
TI  - Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.
AU  - Miyata M
AU  - Hirabayashi Y
AU  - Munakata Y
AU  - Urata Y
AU  - Saito K
AU  - Okuno H
AU  - Yoshida M
AU  - Kodera T
AU  - Watanabe R
AU  - Miyamoto S
AU  - Ishii T
AU  - Nakazawa S
AU  - Takemori H
AU  - Ando T
AU  - Kanno T
AU  - Komagamine M
AU  - Kato I
AU  - Takahashi Y
AU  - Komatsuda A
AU  - Endo K
AU  - Murai C
AU  - Takakubo Y
AU  - Miura T
AU  - Sato Y
AU  - Ichikawa K
AU  - Konta T
AU  - Chiba N
AU  - Muryoi T
AU  - Kobayashi H
AU  - Fujii H
AU  - Sekiguchi Y
AU  - Hatakeyama A
AU  - Ogura K
AU  - Sakuraba H
AU  - Asano T
AU  - Kanazawa H
AU  - Suzuki E
AU  - Takasaki S
AU  - Asakura K
AU  - Suzuki Y
AU  - Takagi M
AU  - Nakayama T
AU  - Watanabe H
AU  - Miura K
AU  - Mori Y
AU  - Michinoku Tocilizumab Study Group
PY  - 2023
JO  - Fukushima journal of medical science
DO  - 10.5387/fms.2022-06
UR  - https://doi.org/10.5387/fms.2022-06
ER  -

APA

M, M., Y, H., Y, M., Y, U., K, S., H, O., M, Y., T, K., R, W., S, M., T, I., S, N., H, T., T, A., T, K., M, K., I, K., Y, T., A, K., K, E., C, M., Y, T., T, M., Y, S., K, I., T, K., N, C., T, M., H, K., H, F., Y, S., A, H., K, O., H, S., T, A., H, K., E, S., S, T., K, A., Y, S., M, T., T, N., H, W., K, M., Y, M., & Group, M. T. S. (2023). Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.. Fukushima journal of medical science. https://doi.org/10.5387/fms.2022-06

Source records